Clinical Pharmacokinetics of Ceftriaxone
- 1 October 1989
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 17 (4), 223-235
- https://doi.org/10.2165/00003088-198917040-00002
Abstract
Ceftriaxone is a third-generation cephalosporin that exhibits saturable plasma protein binding, which influences its pharmacokinetic parameters depending on the dose. Systemic clearance and volume of distribution of total drug show dependence on both concentration and time, whereas for unbound drug these parameters remain constant. The decrease in renal or non-renal clearance with age or in the presence of disease states is often compensated by the concurrent increase in free fraction, resulting in no apparent changes in half-life and no need for dose adjustment. Because of its unusually long plasma half-life, the availability of intramuscular administration and its high intrinsic activity against many organisms, ceftriaxone has become a popular agent in once-daily therapy of infections in paediatric patients, gonococcal infections and outpatient management of pneumonia and osteomyelitis.Keywords
This publication has 99 references indexed in Scilit:
- Ceftriaxone Therapy for Incubating and Early SyphilisThe Journal of Infectious Diseases, 1988
- CeftriaxoneDrugs, 1988
- Effect of cephalosporins on bilirubin-albumin bindingThe Journal of Pediatrics, 1988
- Single-Dose Therapy of Gonococcal Ophthalmia Neonatorum with CeftriaxoneNew England Journal of Medicine, 1986
- Randomised comparison of ceftriaxone and cefamandole therapy in lower respiratory tract infections in an elderly populationJournal of Antimicrobial Chemotherapy, 1986
- Emergence of ceftriaxone-resistant strains of Pseudomonas aeruginosa in cystic fibrosis patientsJournal of Antimicrobial Chemotherapy, 1986
- Randomised observer blind comparative trial of ceftriaxone and penicillin in treating uncomplicated gonorrhoea in men and women.Sexually Transmitted Infections, 1986
- Age-Associated Changes in Ceftriaxone PharmacokineticsClinical Pharmacokinetics, 1986
- Activity of cefotaxime and ceftriaxone alone and in combination with penicillin ampicillin and piperacillin against neonatal meningitis pathogensJournal of Antimicrobial Chemotherapy, 1985
- Clinical Pharmacokinetics of the Third Generation CephalosporinsClinical Pharmacokinetics, 1985